These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6628528)

  • 1. Plasma and synovial fluid concentrations of diclofenac sodium and its major hydroxylated metabolites during long-term treatment of rheumatoid arthritis.
    Fowler PD; Shadforth MF; Crook PR; John VA
    Eur J Clin Pharmacol; 1983; 25(3):389-94. PubMed ID: 6628528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma and synovial fluid concentrations of diclofenac sodium and its hydroxylated metabolites during once-daily administration of a 100 mg slow-release formulation.
    Fowler PD; Dawes PT; John VA; Shotton PA
    Eur J Clin Pharmacol; 1986; 31(4):469-72. PubMed ID: 3469101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of lumiracoxib in plasma and synovial fluid.
    Scott G; Rordorf C; Reynolds C; Kalbag J; Looby M; Milosavljev S; Weaver M; Huff JP; Ruff DA
    Clin Pharmacokinet; 2004; 43(7):467-78. PubMed ID: 15139795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of indomethacin and diclofenac on plasma and synovial prostaglandins in patients with rheumatoid arthritis].
    Szczepański L; Kowalewski J; Miturzyńska-Stryjecka H; Horubała-Bielak G
    Reumatologia; 1983; 21(2):149-56. PubMed ID: 6585872
    [No Abstract]   [Full Text] [Related]  

  • 5. [Transport of sodium diclofenac into synovial fluid].
    Gaucher A; Netter P; Faure G; Sioufi A; Schoeller JP
    Therapie; 1983; 38(4):431-4. PubMed ID: 6648885
    [No Abstract]   [Full Text] [Related]  

  • 6. Simultaneous pharmacokinetics of alclofenace in plasma and synovial fluid in patients with rheumatoid arthritis.
    Thomas GM; Rees P; Dippy JE; Maddock J
    Curr Med Res Opin; 1975; 3(5):264-7. PubMed ID: 241595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synovial fluid concentrations of diclofenac in patients with rheumatoid arthritis or osteoarthritis.
    Benson MD; Aldo-Benson M; Brandt KD
    Semin Arthritis Rheum; 1985 Nov; 15(2 Suppl 1):65-7. PubMed ID: 4081792
    [No Abstract]   [Full Text] [Related]  

  • 8. Synovial fluid and plasma kinetics of repeat dose sustained action tiaprofenic acid in patients with rheumatoid arthritis.
    Nichol FE; Samanta A; Rose CM
    Drugs; 1988; 35 Suppl 1():46-51. PubMed ID: 3359945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma and synovial fluid concentrations of sulphasalazine and two of its metabolites in rheumatoid arthritis.
    Farr M; Brodrick A; Bacon PA
    Rheumatol Int; 1985; 5(6):247-51. PubMed ID: 2906452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro protein binding of diclofenac sodium in plasma and synovial fluid.
    Chan KK; Vyas KH; Brandt KD
    J Pharm Sci; 1987 Feb; 76(2):105-8. PubMed ID: 3572745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ibuprofen kinetics in plasma and synovial fluid of arthritic patients.
    Gallo JM; Gall EP; Gillespie WR; Albert KS; Perrier D
    J Clin Pharmacol; 1986 Jan; 26(1):65-70. PubMed ID: 3950052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma and synovial fluid interleukin-1, interleukin-6 and substance P concentrations in rheumatoid arthritis patients: effect of the nonsteroidal anti inflammatory drugs indomethacin, diclofenac and naproxen.
    Sacerdote P; Carrabba M; Galante A; Pisati R; Manfredi B; Panerai AE
    Inflamm Res; 1995 Nov; 44(11):486-90. PubMed ID: 8597883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolmetin kinetics and synovial fluid prostaglandin E levels in rheumatoid arthritis.
    Dromgoole SH; Furst DE; Desiraju RK; Nayak RK; Kirschenbaum MA; Paulus HE
    Clin Pharmacol Ther; 1982 Sep; 32(3):371-7. PubMed ID: 7105628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of plasma and synovial fluid profiles of standard and controlled-release formulations of ketoprofen in patients with rheumatoid arthritis.
    McCrea JD; Telford AM; Kaye CM; Boyd MW
    Curr Med Res Opin; 1986; 10(2):73-81. PubMed ID: 3519094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disappearance kinetics of solutes from synovial fluid after intra-articular injection.
    Owen SG; Francis HW; Roberts MS
    Br J Clin Pharmacol; 1994 Oct; 38(4):349-55. PubMed ID: 7833225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the effects of different anti-inflammatory drugs on synovial fluid prostanoid concentrations in patients with rheumatoid arthritis.
    Seppälä E; Nissilä M; Isomäki H; Nuotio P; Nykänen E; Laitinen O; Vapaatalo H
    Clin Rheumatol; 1985 Sep; 4(3):315-20. PubMed ID: 3864577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of PGE2 production by nimesulide compared with diclofenac in the acutely inflamed joint of patients with arthritis.
    Duffy T; Belton O; Bresnihan B; FitzGerald O; FitzGerald D
    Drugs; 2003; 63 Suppl 1():31-6. PubMed ID: 14506909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osmosin: its effect on plasma and synovial fluid kinetics of indomethacin.
    Fowler PD; Dawes PT
    Eur J Clin Pharmacol; 1985; 27(6):689-91. PubMed ID: 3987775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of salicylate binding to synovial fluid and plasma protein in patients with rheumatoid arthritis.
    Trnavská Z; Trnavský K
    Eur J Clin Pharmacol; 1980 Nov; 18(5):403-6. PubMed ID: 7439262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-prostaglandin and anti-inflammatory short-term efficacy of piroxicam in rheumatoid arthritis.
    Strusberg A; Montrull H; Meirovich CI
    Eur J Rheumatol Inflamm; 1983; 6(1):41-5. PubMed ID: 6574910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.